References
Nonomura S, Kanagawa H, Makimoto A. Chemical constituents of polygonaceous plants. Studies on the components of Ko-J O-Kon (Polygonum cuspidatum). Yakugaku Zasshi 1963;83:988–90.
Siemann EH, Creasy LL. Concentration of the phytoalexin resveratrol in wine. J Eno Vitic 1992;43:49–52.
Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992;339:1523–6.
Bhat KPL, Kosmeder JW, Pezzuto JM. Biological effects of resveratrol. Antioxid Redox Signal 2001;3:1041–64.
Wu JM, Wang ZR, Hsieh TC, Bruder JL, Zou JG, Huang YZ. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine. Int J Mol Med 2001;8:3–17. Review.
Chen YR, Yi FF, Li XY, et al. Resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction. Cardiovasc Drugs Ther. 2008;22: This issue.
Hattori R, Otani H, Maulik N, Das DK. Pharmacological preconditioning with resveratrol: role of nitric oxide. Am J Physiol Heart Circ Physiol 2002;282:H1988–95.
Imamura G, Bertelli AA, Bertelli A, Otani H, Maulik N, Das DK. Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice. Am J Physiol Heart Circ Physiol 2002;282:H1996–2003.
Hung LM, Chen JK, Huang SS, Lee RS, Su MJ. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc Res 2000;47:549–55.
Bak I, Papp G, Turoczi T, et al. The role of heme oxygenase-related carbon monoxide and ventricular fibrillation in ischemic/reperfused hearts. Free Radic Biol Med 2002;33:639–48.
Bak I, Szendrei L, Turoczi T, et al. Heme oxygenase-1 related carbon monoxide production and ventricular fibrillation in isolated ischemic/reperfused mouse myocardium. FASEB J 2003;03-0032fje.
Clark JE, Naughton P, Shurey S, et al. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 2003;93:e2–8.
Lee TM, Lin MS, Chang NC. Effect of ATP-sensitive potassium channel agonists on ventricular remodeling in healed rat infarcts. J Am Coll Cardiol 2008;51:1309–18.
Basly JP, Marre-Fournier F, Le Bail JC, Habrioux G, Chulia AJ. Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol. Life Sci 2000;66:769–77.
Liew R, Stagg MA, MacLeod KT, Collins P. The red wine polyphenol, resveratrol, exerts acute direct actions on guinea-pig ventricular myocytes. Eur J Pharmacol 2005;519:1–8.
Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 2004;32:1377–82.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liew, R. Cardioprotective and Antiarrhythmic Effects of Resveratrol—a Modern Perspective on an Old Treatment. Cardiovasc Drugs Ther 22, 427–428 (2008). https://doi.org/10.1007/s10557-008-6145-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10557-008-6145-4